We identified CCL2 as a key player in mediating STAT3 activation and epithelial–mesenchymal transition (EMT) of PCa cells and addressed the key problem of why targeting AR with siRNA might lead to promotion of PCa metastasis. The gene discussed is STAT3; the disease is posterior cortical atrophy.